SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Threshold Pharmaceuticals, Inc. to Molecular Templates, Inc. is Fair to Shareholders – THLD

NEW YORK, NY / ACCESSWIRE / May 23, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) stock prior to March 17, 2017.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Threshold to Molecular Templates, Inc. Threshold shareholders will own approximately 34.4% of the newly formed entity. To learn more about the action and your rights, go to: http://zlk.9nl.com/threshold, or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars
for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 464019